Conditions: Type 2 Diabetes Mellitus
Keywords: Diabetes Mellitus Dapagliflozin Placebo Insulin resistance Insulin sensitivity
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 55
Healthy volunteers: no

Brief summary:
This is an 8-week, single centre, randomized, parallel-group, double-blind, placebo-controlled Phase IV study to evaluate the effect of dapagliflozin on tissue specific insulin sensitivity in patients with Type 2 diabetes mellitus

Detailed description:

Arms:
arm 1: Dapagliflozin Once Daily 10 mg arm 2: Matching placebo for Dapagliflozin Once Daily 10 mg

Interventions: intervention 1: Dapagliflozin intervention 2: Placebo
Intervention descriptions: intervention 1: Dapagliflozin 10 mg Tablets, Oral, Once Daily, 8 weeks intervention 2: Matching placebo to Dapagliflozin 10 mg Tablets, Oral, Once Daily, 8 weeks

Protocol document: